Evgen Pharma (EVG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.64p
   
  • Change Today:
      0.035p
  • 52 Week High: 6.85
  • 52 Week Low: 1.53
  • Currency: UK Pounds
  • Shares Issued: 274.89m
  • Volume: 201,395
  • Market Cap: 4.50m
  • RiskGrade: 304

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Sep-23 Interim 0.40 (1.46) (0.53)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-19 n/a (3.12) (2.70)p n/a n/a n/a n/a 0.0%
31-Mar-20 n/a (3.17) (2.07)p n/a n/a n/a n/a 0.0%
31-Mar-21 0.19 (3.21) (1.82)p n/a n/a n/a n/a 0.0%
31-Mar-22 n/a (3.17) (0.99)p n/a n/a n/a n/a 0.0%
31-Mar-23 0.44 (5.01) (1.47)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-24 0.40 (4.10) (1.20)p n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Evgen Pharma Market Data

Currency UK Pounds
Share Price 1.64p
Change Today 0.035p
% Change 2.21 %
52 Week High 6.85
52 Week Low 1.53
Volume 201,395
Shares Issued 274.89m
Market Cap 4.50m
RiskGrade 304

Evgen Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.56% above the market average8.56% above the market average8.56% above the market average8.56% above the market average8.56% above the market average
71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average
Price Trend
90.07% below the market average90.07% below the market average90.07% below the market average90.07% below the market average90.07% below the market average
72.88% below the sector average72.88% below the sector average72.88% below the sector average72.88% below the sector average72.88% below the sector average
Income Not Available
Growth Not Available

Evgen Pharma Dividends

No dividends found

Trades for 30-Nov-2023

Time Volume / Share Price
10:06 200,000 @ 1.79p
08:50 1,395 @ 1.80p

Evgen Pharma Key Personnel

CEO Huw Jones

Top of Page